Subscribe to RSS
DOI: 10.1055/s-0030-1260026
A New Method for the Synthesis of 1-Aryl-1,2,4-triazole Derivatives
Publication History
Publication Date:
05 May 2011 (online)
Abstract
A new and convenient one-step recyclization method for the synthesis of ethyl 1-aryl-5-oxo-4,5-dihydro-1H-1,2,4-triazole-3-carboxylates is reported. Various ethyl chloro(2-arylhydrazinylidene)ethanoates react with thiazolidine-2,4-dione in the presence of potassium hydroxide to produce the 1-aryl-1,2,4-triazole derivatives in moderate to good yields. The procedure is economical, environmentally friendly and simple to perform.
Key words
1,2,4-triazoles - diazonium salts - ring-opening - thiazolidine-2,4-dione - heterocyclization
- 1
Negwer M.Scharnow H.-G. Organic-Chemical Drugs and Their Synonyms Wiley-VCH; Weinheim: 2001. - 2
Shimizu S.Endo T.Izumi K.Mikamiyama H. Org. Process Res. Dev. 2007, 11: 1055 - 3
Lin R.Connolly PJ.Huang S.Wetter SK.Lu Y.Murray WV.Emanuel SL.Gruninger RH.Fuentes-Pesquera AR.Rugg CA.Middleton SA.Jolliffe LK. J. Med. Chem. 2005, 48: 4208 - 4
Ebdrup S.Sørensen LG.Olsen OH.Jacobsen P. J. Med. Chem. 2004, 47: 400 - 5
Marino JP.Fisher PW.Hofmann GA.Kirkpatrick RB.Janson CA.Johnson RK.Ma C.Mattern M.Meek TD.Ryan MD.Schulz C.Smith WW.Tew DG.Tomazek TA.Veber DF.Xiong WC.Yamamoto Y.Yamashita K.Yang G.Thompson SK. J. Med. Chem. 2007, 50: 3777 - 6
Jagerovic N.Hernandez-Folgado L.Alkorta I.Goya P.Navarro M.Serrano A.de Fonseca FR.Dannert MT.Alsasua A.Suardiaz M.Pascual D.Martín MI. J. Med. Chem. 2004, 47: 2939 - 7
Lowe RF.Nelson J.Dang TN.Crowe PD.Pahuja A.McCarthy JR.Grigoriadis DE.Conlon P.Saunders J.Chen C.Szabo T.Chen TK.Bozigian H. J. Med. Chem. 2005, 48: 1540 - 8
Jadhav GR.Shaikh MU.Kale RP.Shiradkar MR.Gill CH. Eur. J. Med. Chem. 2009, 44: 2930 -
9a
Kwon S.Wee K.-R.Kim A.-L.Kang SO. J. Phys. Chem. Lett. 2010, 1: 295 -
9b
Jiang X.Zhang Z.Zhao W.Zhu W.Zhang B.Xu S. J. Phys. D: Appl. Phys. 2000, 33: 473 -
10a
Temple C. Triazoles 1,2,4, In Chemistry of Heterocyclic CompoundsMontgomery JA. John Wiley & Sons; New York: 1981. -
10b
Shaker RM. ARKIVOC 2006, (ix): 59 -
10c
Al-Masoudi IA.Al-Soud YA.Al-Salihi NJ.Al-Masoudi NA. Chem. Heterocycl. Compd. 2006, 42: 1377 -
10d
Balasubramanian M.Keay JG.Scriven EFV.Shobana N. Heterocycles 1994, 37: 1951 -
10e
Kofman TP. Russ. J. Org. Chem. 2002, 38: 1231 ; Zh. Org. Khim. 2002, 38, 1289 - 11
Mustafa SM.Nair VA.Chittoor JP.Krishnapillai S. Mini-Rev. Org. Chem. 2004, 1: 375 - 12
Yamazaki C.Sakai M.Miyamoto Y.Suzuki N. J. Chem. Soc., Perkin Trans. 1 1987, 1567 -
13a
Danagulyan GG.Panosyan GA.Sahakyan LG. Chem. Heterocycl. Compd. 2007, 43: 996 -
13b
Roy RU.Desai AR.Desai KR. E-J. Chem. 2005, 2: 1 -
14a
Katritzky AR.Qi M.Feng D.Zhang G.Griffith MC.Watson K. Org. Lett. 1999, 1: 1189 -
14b
Boeglin D.Cantel S.Heitz A.Martinez J.Fehrentz J.-A. Org. Lett. 2003, 5: 4465 -
14c
Larsen SD.DiPaolo BA. Org. Lett. 2001, 3: 3341 -
14d
Theoclitou M.-E.Delaet NGJ.Robinson LA. J. Comb. Chem. 2002, 4: 315 -
15a
Rostamizadeh S.Tajik H.Yazdanfarahi S. Synth. Commun. 2003, 33: 113 -
15b
Yeung K.-S.Farkas ME.Kadow JF.Meanwell NA. Tetrahedron Lett. 2005, 46: 3429 - 16
Matiichuk VS.Potopnyk MA.Obushak ND. Russ. J. Org. Chem. 2008, 44: 1352 ; Zh. Org. Khim. 2008, 44, 1368 -
17a
Peng Y.Zhang Q.Arora S.Keenan SM.Kortagere S.Wannemacher KM.Howells RD.Welsh WJ. Bioorg. Med. Chem. 2009, 17: 6442 -
17b
Krauth F.Friedemann R.Rüttinger H.-H.Frohberg P. ARKIVOC 2009, (vii): 150 -
17c
Catarzi D.Colotta V.Varano F.Filacchioni G.Gratteri P.Sgrignani J.Galli A.Costagli C. Chem. Pharm. Bull. 2008, 56: 1085 -
17d
Awadallah AM.Zahra JA. Molecules 2008, 13: 170 -
17e
Catarzi D.Colotta V.Varano F.Lenzi O.Filacchioni G.Trincavelli L.Martini C.Montopoli C.Moro S. J. Med. Chem. 2005, 48: 7932 -
17f
Catarzi D.Colotta V.Varano F.Calabri FR.Filacchioni G.Galli A.Costagli C.Carlà V. J. Med. Chem. 2004, 47: 262 -
17g
Catarzi D.Colotta V.Varano F.Filacchioni G.Galli A.Costagli C.Carlà V. J. Med. Chem. 2001, 44: 3157 -
18a
Abbas IM.Riyadh SM.Abdallah MA.Gomha SM. J. Heterocycl. Chem. 2006, 43: 935 -
18b
Asmaa ME.-D.Salwa E.Aisha H. Phosphorus, Sulfur Silicon Relat. Elem. 2006, 181: 53 -
18c
Mosselhi MAN.Abdallah MA.Farghaly TA.Shawali AS. Monatsh. Chem. 2004, 135: 211 -
18d
Shawali AS.Elsheikh S.Párkányi C. J. Heterocycl. Chem. 2003, 40: 207 -
20a
Turkevych NM.Vvedenskij VM.Petlichnaya LP. Ukr. Khim. Zh. 1961, 27: 680 ; Chem. Abstr. 1962, 56, 73455 -
20b
Prashantha Kumar BR.Nanjan MJ. Bioorg. Med. Chem. Lett. 2010, 20: 1953 - 21
Sheldrick GM. Acta Crystallogr., Sect. A 2008, 64: 112
References
A colorless crystal of approximate dimensions 1.0 × 0.05 × 0.05 mm was used. Diffraction data were collected at 100 K using a Bruker Kappa CCD diffractometer with graphite monochromated MoKα radiation (0.71073 Å). Lorentz-polarization correction was employed, but not for absorptions. The structure was solved by direct methods (SHELXS-97)²¹ and refined on F² using the full-matrix least-squares method (SHELXL-97).²¹ Formula: C11H10ClN3O3, orthorhombic, space group = P212121, a = 4.3850 (2), b = 10.5690 (7), c = 24.8990 (16) Å, V = 1153.95 (12) ų, R 1 = 0.0804 [I>2σ(I)], wR 2 = 0.2070 for all data. The hydrogen atoms were added geometrically and refined with the riding model. The crystallographic data for compound 5f have been deposited with the Cambridge Crystallographic Data Centre as supplementary publication number CCDC 804995. These data can be obtained free of charge via www.ccdc.cam.ac.uk, or on application to the Cambridge Crystallographic Data Centre, 12 Union Road, Cambridge CB2 1EZ, UK.